Scott Snyder
Chief Digital Officer
Expertise:
Scott serves as EVERSANA’s Chief Digital Officer, driving digital transformation for employees, clients, and the patients we serve. He brings more than 30 years of experience in emerging technologies and digital transformation across both global 1000 companies and startup ventures. Scott is an industry expert on how enterprises can leverage digital and other emerging technologies to accelerate innovation and new venture creation. He has held executive positions with several Fortune 500 companies and has been a featured thought leader in publications including CIO, WIRED, Forbes, Knowledge@Wharton, Los Angeles Times and The Wall Street Journal. Scott is also the co-author of Goliath’s Revenge, a book focused on how established companies can turn the table through digital disruption.
He earned his B.S., M.S., and Ph.D. in Systems Engineering from the University of Pennsylvania. Scott is currently a Senior Fellow in the Management Department at the Wharton School.
Articles by Scott Snyder
Unlocking the Power of Data, Artificial Intelligence and Digital Innovations to Revolutionize Care for Rare Disease Patients
Rare diseases and developing and distributing the therapies that treat them create highly complex challenges for pharmaceutical manufacturers, and certainly for the patients and providers impacted by them every day. Because these diseases are often extremely difficult to diagnose and treat effectively, advancements toward alleviating the toll they take on patients’ lives are often few […]
When Will “Digital Health” Just Become Health?
Despite the significant drop in funding in 2022, digital health is here to stay. It encompasses a wide range of technologies and innovations, from telemedicine to wearables to artificial intelligence (AI). Telehealth has reached 80% adoption and wearable ownership is approaching 50% in markets like the US. And the promise of digital health is immense: […]
Can Omnichannel Deliver the ROI We Need?
As advances in technology continue to modify the biopharma industry at an increasingly rapid pace, embracing digital innovation is crucial to generating success in today’s modern landscape. In this webinar hosted by Pharmaceutical Executive, industry experts from multiple organizations discuss how pharmaceutical companies can best utilize omnichannel beyond traditional strategies to create more streamlined and […]
Can Telehealth Accelerate the Uptake of Digital Therapeutics?
Introducing an industry-first, integrated direct-to-patient telehealth solution for digital therapeutics that includes patient engagement, telehealth consultation, prescription issuing and dispensing, and patient support. Fueled by the pandemic, telehealth has moved from an interest to expectation for most patients, with 76% of patients reporting they are comfortable using telehealth. Digital medicine solutions, including digital therapeutics (DTx), […]
Missed Connection or Meant to Be?
EVERSANA is raising the questions the industry is thinking but is too afraid to ask aloud: Has omnichannel lived up to its promise of the “right message at the right time” to drive meaningful results that wouldn’t otherwise be realized by traditional sales and marketing strategies? Are those “seamless brand experiences” integrating the right mix […]
8 Healthtech Trends For 2023
2023 is here, and with it comes foreshadowing of what the year will bring. In the life sciences and pharmaceutical industry, it’s not different. In fact, many have already made their predictions for the new year, including our experts at EVERSANA INTOUCH, who shared their 7th annual white paper on “Trends That Will Shape Pharma […]
Digital-First Future and the “Data Flywheel”: How Can Pharma Use the Combination of Data, AI, and Content to Drive Successful Product Launches
In this episode of Pharma Launch Secrets, Bozidar Jovicevic, CEO of Evermed, is joined by Scott Snyder, Chief Digital Officer at EVERSANA to discuss: What is the best way to orchestrate personalized digital experiences for HCPs and patients? What is the “data flywheel,” and how can it give pharma companies a competitive advantage? Who is […]
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
By applying transformative commercialization models, nurturing digital transformation and trailblazing in global expansion, we can get therapies to patients around the world who are still waiting for treatment options. For the past two years, the pharmaceutical industry has proven that it can adapt to change. In 2020, pharma pivoted to manage the coronavirus pandemic, and […]
The Power to Know When: Balancing High-Tech and High-Touch Solutions to Eliminate Access, Affordability and Adherence Barriers
Forty percent of consumers prefer speaking to a real person on the phone, and for more complex issues, 80% want to speak to a live service agent. In the increasingly virtual world we live in, one thing remains clear: we still crave human interactions. As a result, pharma manufacturers need to understand how patients and […]
Options and Insights for Successful Development and Launch
Pharma Sponsored Digital Health Solutions and Digital Therapeutics (DTx): Options and Insights for Successful Development and Launch Listen to EVERSANA’s Scott Snyder and Jim O’Donoghue of S3 Connected Health in this recorded webinar as they share insights on the driving forces behind the different types of digital health solutions and #DTx and provide actionable advice on what to consider when […]
Reimagining the SpecialtyRx Patient Journey Through the Lens of a Digital Consumer
Nearly 32% of Americans suffer from complex, chronic or rare conditions, such as autoimmune diseases, genetic disorders or cancer, many of which require a specialty prescription therapy. Despite being only 3% of overall prescriptions, specialty medications represent nearly 50% of the overall prescription drug spend in the U.S. While we have moved to the on-demand […]
Disrupting Healthcare from the Inside: How Incumbents Can Lead Change
The following opinion piece was written by Scott Snyder, Chief Digital Officer, for Knowledge@Wharton. Outsider attempts to reinvent healthcare have done little to move the needle despite billions invested in promising concepts like Microsoft’s HealthVault, IBM’s Watson Health, Theranos, Google’s Contact Lens, Drugstore.com, and more recently Helix and Haven. These were backed by some of […]